Watch-out database → Detailed ingredient information:
Restricted as per EC regulation 1223/2009?
Potential endocrine disruptor – Group A
|Date of update||Deadline||Content of update||Reference||Source||Obelis articles|
|10/11/2022||01/07/2023||There is a potential risk to human health arising from the use of Butylated Hydroxytoluene in mouthwash, toothpaste and other leave-on and rinse off products when the concentration of that substance exceeds certain levels. Therefore, the use of Butylated Hydroxytoluene in those products should be restricted to a maximum concentration of 0,001 %, 0,1 % and 0,8 % respectively.||Commission Regulation (EU) 2022/2195||EC|
|N/A||N/A||According to the draft Regulation, BHT will be added to Annex III. Its use will be permitted: (1) In mouthwash products, up to 0.001% (2) In toothpastes, up to 0.1% (3) In other leave-on and rinse-off products, up to 0.8%. The Regulation is expected to be published by the end of 2022.||Draft Regulation - WTO Notification||EC||Amendments to Annexes III and VI to the EU Cosmetics Regulation|
|02/12/2021||N/A||Butylated Hydroxytoluene (BHT) is suspected to have endocrine-disrupting properties. Hence, the SCCS is of the opinion that BHT is safe as: (1) up to 0.001% in mouthwash (2) up to 0.1% in toothpaste (3) up to a maximum concentration of 0.8% in other leave-on and rinse-off products.||Final Opinion SCCS/1636/21||SCCS|